- Home
- OKYO vs DRIO Comparison
OKYO vs DRIO Comparison
Compare OKYO & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OKYO | DRIO |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.3M | 61.8M |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | OKYO | DRIO |
|---|---|---|
| Price | $1.66 | $9.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $6.33 | ★ $60.00 |
| AVG Volume (30 Days) | ★ 320.3K | 8.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 9.05 |
| Revenue | N/A | ★ $7,394,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $16.15 |
| P/E Ratio | ★ N/A | $1.00 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $1.03 | $0.38 |
| 52 Week High | $3.35 | $17.74 |
Technical Indicators
Market Signals| Indicator | OKYO | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 39.57 | 37.06 |
| Support Level | $1.55 | $0.56 |
| Resistance Level | $2.35 | $12.36 |
| Average True Range (ATR) | 0.10 | 0.54 |
| MACD | 0.01 | -0.16 |
| Stochastic Oscillator | 41.22 | 9.38 |
Price Performance
Historical ComparisonAbout OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.